Equity Risk Sciences Introduces Groundbreaking Stock Risk Ratings
July 14th, 2025 5:10 PM
By: Newsworthy Staff
Equity Risk Sciences launches as the first independent stock risk rating agency in the U.S., offering data-driven tools to help fiduciaries and institutional investors assess stock price change probabilities and magnitudes.

Equity Risk Sciences (ERS) has emerged as the United States' inaugural independent Stock Risk Rating Agency, introducing a novel approach to evaluating stock price volatility through quantitative, evidence-based ratings. Utilizing proprietary models that analyze SEC-filed financial data alongside 35 years of price history, ERS aims to identify financial attributes and trends predictive of future stock price movements. This initiative is particularly relevant for fiduciaries and institutional investors in search of unbiased, conflict-free analysis grounded in data science and artificial intelligence.
Among ERS's key offerings are the Fiduciary Stock Navigator (FSN) and the Loss Indicator (LI), ratings designed to assess a stock's fiduciary suitability and financial vulnerability, respectively. The FSN provides a composite rating focusing on overall fiduciary suitability and the likelihood of significant loss, while the LI zeroes in on financial statement strength and deterioration. These tools are based on extensive statistical analysis linking financial statement deterioration to future stock price declines, offering a scientific basis for risk assessment.
ERS's ratings, including the 'A+' for stocks with strong financials and low downside risk, and the '-3' for those with high financial risk, are backed by a 25-year study of over 400,000 stock ratings. The agency emphasizes its commitment to transparency and objectivity, stating it does not issue recommendations, manage money, or accept payments from rated companies. According to Raymond Mullaney, Founder and CEO of ERS, the agency's mission is to equip fiduciaries with the necessary tools to avoid preventable losses through data analytics and objective ratings.
This development is timely, as it addresses the need for fiduciaries to have access to objective data for risk evaluation amidst increasing regulatory scrutiny. ERS's ratings challenge the notion that significant stock declines are an unavoidable aspect of long-term investing, highlighting the importance of financial fundamentals in preventing major losses. By providing actionable risk ratings, ERS aims to support investment professionals in fulfilling their legal duty of care and enhancing portfolio risk management strategies.
Source Statement
This news article relied primarily on a press release disributed by citybiz. You can read the source press release here,
